Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 24, 1994 - Issue 4
15
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Stereoselective disposition and metabolism of pinacidil in rat

&
Pages 329-338 | Received 15 Jul 1993, Accepted 11 Nov 1993, Published online: 22 Sep 2008
 

Abstract

1. An hplc method has been established for the determination of the enantiomer ratios of pinacidil and pinacidil-pyridine-N-oxide (M-1), using a β-cyclodextrin-containing mobile phase.

2. Shortly after the administration of racemic pinacidil (2 mg/kg, i.v. or oral) to rat, the enantiomer ((+)/(-)) ratios of pinacidil in plasma were about 1 (i.v.) or < 1 (oral), whereas those of M-1 were > 1; both ratios increased with time. The (+)/(-) ratios of M-1 and pinacidil in 0.24 h urine samples were 0.65 (i.v.), 0.63 (oral), and 2.09 (i.v.), and 1.56 (oral), respectively, in male rat, and 0.76 (i.v.), 0.77 (oral) and 1.79 (i.v.), and 1.48 (oral), respectively, in female rat.

3. No isomerization of (+)- or (-)-pinacidil was observed during incubation with liver slices, and there was no stereoselectivity in the protein binding of the drug. An (-)-enantiomer-rich M-1, however, was produced after incubation of (±)- pinacidil with liver slices. The N-oxidation of (-)-pinacidil exhibited a higher stereoselectivity in males than females (the (+)/(-) ratio of M-1 in male, 0.55; female, 0.68).

4. These results indicated that the stereoselective disposition of pinacidil in rat was due, in large part, to the stereoselective N-oxidation of this drug in the liver.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.